EFTA00592853.pdf

The Foundation for Medical Research in short. . . FONDATION RECHERCHE MEDICALE Created in 1947 by famous researchers, one of which was Prof. Jean Bernard. Recognized as Public Utility Fondation since 1965 - Being independent, it receives no French or European funding. Objective: contributes to the development of innovative and pioneering public research, and accelerates the advances in fighting against all illnesses. Support between 400 and 450 new research studies, which requires c45 million in funding each year. Stephanie Climent-Grandcourt: Director of Philanthropy and Trust Tel. 01 44 39 75 96 • stephance.clement-grandcourtef rm.org EFTA00592853 A unique position at the core of research DONOR GUARANTEE The Foundation is a major actor in the field of medical to have a significant impact research. on the fight against disease, Through the force of its financial support and intimate and provide support to work knowledge of research requirements and priorities in that matches urgent public public health, the Foundation works effectively to respond quickly to the needs of research teams. health issues. The Foundation supports research for all pathologies. the possibility to choose It is involved in all areas of research: cancer, neurologi- cal, cardiovascular, and infectious diseases and promotes the pathology and project major advancements in health. to be financed. The Foundation does not carry out research. It selects and finances the most promising French research the assurance of funding teams tat the INSERM, at the CNRS, at universities, in hos- highly-promising research pitals'. via a high-level scientific advisory board made up of researchers and doctors (30% of the 1.500 projects that with excellence as the only are considered are eventually selected). criteria for selection. The Foundation oversees the progress of all of the work follow-up on the impact of that it finances. the donation; the possibility The staff at the Foundation's Scientific Department carries to meet with the researchers; out scientific and financial monitoring. information on research progress. Vehicles of philanthropy available to the donor: Support for a research team or an emerging researcher ElOk (€2,500 after a wealth-tax deduction) Creation of an Award on behalf of the donor E20k/year for fi te years (€5.000/year after a wealth-tax deduction) Creation of a sheltered foundation (see inset) il €50k/year for three years (E12,500/year after a wealth-tax deduction) Stephanie Clement-Grandcourt: Director of Philanthropy and Trus: Tel. 01 44 39 75 96 • stephanie.ctement-grandcourtefrm.org EFTA00592854 Customized asset management services: A team of legal and financial experts is at the donor's disposal, along with their advisors, in order to optimize the legal aspects of their commitment, according to donor wishes. Reminder of tax deductions: LiT I 75% deduction of the amount of the donation from the wealth tax (with a maximum of E50k1. Amount of the wealth Amount of the Amount of Amount of the Actual cost tax to be paid before donation to the the wealth-tax wealth-tax after of the the donation FRM 'Foundation for deduction tax deduction* donation Medical Research) 15 000 E 20 000 E 15 000 oe 5 000 € 30 000 E a 40 000 E 30 000 € 0€ 10 000 € 50 000 E 66 667 € 50 000 E 0€ 16 667 € •To reduce the wealth tax to 0, the amount of the tax must be divided by 0.75, which gives you the amount of the donation. Use of the donations: The possibility to create Out of E100 from public sheltered foundations: donations in 2014: • Choice of the name and the foundation's focus area. ial missions • The same tax benefits as for donations to the Foundation. • Choice of research teams to be funded. el 5,4 Fundraising • Organized meetings with funded researchers. • Accurate tracking of your philanthropic investment. 04,1 • For individuals: a minimum financial commitment Running costs* of €50K/year for three years (€12.500/year after a wealth- *the running costs are tax deduction). covered by the Foundation's financial proceeds. Stephanie Clement-Grandcourt: Director of Philanthropy and Trust Tel. 01 44 39 75 96 • stephanie.clement-grandcourtefrm.org EFTA00592855  Major advances in health issues and the fight against disease... • The measles vaccine: Meeting exceptional I the new anti-cancer weapon researchers... At the Nantes-Angers Cancer Center Research, INSERM Director of Research Marc Gregoire's team Jules Hoffmann, is working on an inventive application of the measles Nobel Prize in Medicine in 2011 vaccine: treating a severe form of cancer caused by Foundation for Medical Research exposure to asbestos. Grand Prize in 2004. €249K in funding Francoise Barre-Sinoussl, • Alzheimer's Disease: Nobel Prize in Medicine in 2008 the hope for gene therapy At the Atomic Energy Commission, INSERM Director Jean Weissenbach, of Research Nathalie Cartier is fighting the progres- CNRS Gold Medal in 2008 and sion of Alzheimer's Disease through gene therapy (a Foundation for Medical Research method using genes and the information carried wit- Grand Prize in 2007. hin them to treat the disease'. Following convincing results in mice, her team is preparing the move to clinical trials. €400K in funding • Cancer of the esophagus: * Documentation available upon request • Brochure about the Founda- tion's sheltered foundations constructing biosynthetic esophagi to re 'lace dama.ed orians Jerome Larghero, in charge of the Cellular Therapy Bu- siness Unit at Satin-Louis Hospital, and his team are wor- king on creating esophageal segments through tissue • Brochure about the 2016 engineering. A world first, this technique could constitute wealth tax an attractive alternative to current procedures 'grafting from the patient's stomach or from segments of their colon), which today presents the risk of post-operative complications or death. €170K in funding Procedures and verification to insure you that your donation will be put to good use: certification of annual accounts by an independent Auditor, sending all financial statements to all donors, • organization of annual lunches to present the financial statements, licensed by the Committee of the Charter for Trust in Fundraising in France. Stephanie Clement-Grandcourt: EFTA00592856